CIGNA Co. (NYSE:CI) Chairman Isaiah Harris, Jr. sold 212 shares of the business’s stock in a transaction on Monday, December 11th. The stock was sold at an average price of $209.35, for a total value of $44,382.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
Shares of CIGNA Co. (NYSE:CI) traded down $2.15 on Friday, reaching $203.09. The company’s stock had a trading volume of 736,245 shares, compared to its average volume of 1,207,109. The firm has a market cap of $50,071.84, a PE ratio of 22.24, a P/E/G ratio of 1.55 and a beta of 0.50. The company has a current ratio of 0.39, a quick ratio of 0.39 and a debt-to-equity ratio of 0.37. CIGNA Co. has a 12 month low of $133.11 and a 12 month high of $212.46.
CIGNA (NYSE:CI) last posted its quarterly earnings data on Thursday, November 2nd. The health services provider reported $2.83 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.36 by $0.47. The company had revenue of $10.38 billion during the quarter, compared to analyst estimates of $10.17 billion. CIGNA had a return on equity of 18.85% and a net margin of 5.74%. CIGNA’s quarterly revenue was up 5.1% on a year-over-year basis. During the same period in the previous year, the business earned $1.94 EPS. equities research analysts predict that CIGNA Co. will post 10.34 EPS for the current fiscal year.
Several research firms have commented on CI. Zacks Investment Research raised CIGNA from a “hold” rating to a “buy” rating and set a $231.00 target price on the stock in a report on Friday, December 22nd. Citigroup increased their target price on CIGNA from $198.00 to $231.00 and gave the company a “buy” rating in a report on Friday, November 3rd. Morgan Stanley upped their price target on CIGNA from $195.00 to $223.00 and gave the stock an “overweight” rating in a research report on Friday, November 3rd. Jefferies Group upped their price target on CIGNA from $221.00 to $231.00 and gave the stock a “buy” rating in a research report on Friday, November 3rd. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $220.00 target price (up previously from $185.00) on shares of CIGNA in a research report on Friday, November 3rd. Two analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus target price of $202.56.
A number of large investors have recently bought and sold shares of CI. IFP Advisors Inc increased its stake in shares of CIGNA by 5.3% during the 2nd quarter. IFP Advisors Inc now owns 2,296 shares of the health services provider’s stock worth $384,000 after purchasing an additional 116 shares in the last quarter. First Trust Advisors LP grew its stake in CIGNA by 1.1% in the 2nd quarter. First Trust Advisors LP now owns 117,015 shares of the health services provider’s stock worth $19,587,000 after acquiring an additional 1,261 shares during the period. Savant Capital LLC grew its stake in CIGNA by 45.9% in the 2nd quarter. Savant Capital LLC now owns 2,290 shares of the health services provider’s stock worth $383,000 after acquiring an additional 720 shares during the period. LMR Partners LLP purchased a new stake in CIGNA in the 2nd quarter worth approximately $1,479,000. Finally, State of Wisconsin Investment Board grew its stake in CIGNA by 18.7% in the 2nd quarter. State of Wisconsin Investment Board now owns 326,617 shares of the health services provider’s stock worth $54,672,000 after acquiring an additional 51,490 shares during the period. 87.74% of the stock is currently owned by hedge funds and other institutional investors.
WARNING: “Insider Selling: CIGNA Co. (NYSE:CI) Chairman Sells 212 Shares of Stock” was posted by The Lincolnian Online and is the property of of The Lincolnian Online. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international trademark & copyright laws. The correct version of this article can be read at https://www.thelincolnianonline.com/2017/12/31/cigna-corporation-ci-chairman-sells-44382-20-in-stock-updated-updated.html.
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.